Related Experiment Video
Updated: Jun 19, 2026
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Pathophysiological basis of translational stroke research
Konstantin-Alexander Hossmann1
1Max-Planck-Institute for Neurological Research, D-50931 Cologne, Germany. hossmann@nf.mpg.de
Abstract:
The high incidence and the devastating consequences of stroke call for efficient therapies but despite extensive experimental evidence of neuroprotective improvements, most clinical treatments have failed. The poor translational success is attributed to the inappropriate selection of clinically irrelevant animal models, the inappropriate focus on clinically irrelevant injury pathways and the inappropriate estimation of the length of therapeutic windows. To substantiate this conclusion, the pathophysiology of experimental stroke is reviewed. Particular emphasis is placed on the importance of collateral pathways, the penumbra concept and the viability thresholds of ischaemia, the haemodynamic and molecular mechanisms of injury evolution and the effect of secondary complications, notably inflammation and brain oedema. The comparison of permanent and transient focal ischaemia, on the one hand, and between mechanical and thrombolytic reperfusion, on the other, reveal basic differences in the mechanisms and dynamics of injury evolution which are of paramount importance for the proper targeting and time window of therapeutic interventions. These differences must be considered for adequate modelling of preclinical stroke studies to avoid unsuccessful translation of experimental data to the clinical setting.
Insights
Translational failure in stroke therapy stems from using irrelevant animal models and ignoring critical injury dynamics. Optimizing preclinical stroke models is crucial for successful clinical treatments.
Area of Science:
- Neuroscience
- Translational Medicine
- Cerebrovascular Research
Background:
- Stroke is a leading cause of death and disability, necessitating effective treatments.
- Despite promising preclinical data, most stroke therapies fail in clinical trials.
- Poor translation is linked to flawed experimental models and therapeutic timing.
Purpose of the Study:
- To review experimental stroke pathophysiology.
- To highlight critical factors for successful translation to clinical practice.
- To emphasize the importance of appropriate preclinical stroke modeling.
Main Methods:
- Review of experimental stroke pathophysiology literature.
- Emphasis on collateral pathways, penumbra, and ischemia viability thresholds.
- Comparison of permanent vs. transient focal ischemia and reperfusion methods.
Main Results:
- Experimental models often lack clinical relevance.
- Injury evolution mechanisms differ significantly between stroke types and reperfusion strategies.
- Understanding these differences is key for therapeutic targeting and timing.
Conclusions:
- Inappropriate animal models and focus on irrelevant pathways hinder clinical translation.
- Accurate modeling of stroke pathophysiology, including collateral circulation and therapeutic windows, is essential.
- Improved preclinical study design is vital to bridge the gap between experimental findings and clinical outcomes.
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
01:29Hemorrhagic Stroke ll: Pathophysiology
01:15Ischemic Stroke l: Introduction
01:27Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...